BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18262654)

  • 1. Serious life events among resistant and non-resistant MDD patients.
    Amital D; Fostick L; Silberman A; Beckman M; Spivak B
    J Affect Disord; 2008 Oct; 110(3):260-4. PubMed ID: 18262654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic impact of depression: resistance or severity?
    Fostick L; Silberman A; Beckman M; Spivak B; Amital D
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):671-5. PubMed ID: 20624674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of negative life events in subtypes of major depressive disorder.
    Kohn Y; Zislin J; Agid O; Hanin B; Troudart T; Shapira B; Bloch M; Gur E; Ritsner M; Lerer B
    Compr Psychiatry; 2001; 42(1):57-63. PubMed ID: 11154717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAOI efficacy and safety in advanced stage treatment-resistant depression--a retrospective study.
    Amsterdam JD; Shults J
    J Affect Disord; 2005 Dec; 89(1-3):183-8. PubMed ID: 16213594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course and outcome of major depressive disorder in non-referred adolescents.
    Essau CA
    J Affect Disord; 2007 Apr; 99(1-3):191-201. PubMed ID: 17049997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.
    Papakostas GI; Petersen T; Mischoulon D; Hughes ME; Spector AR; Alpert JE; Fava M; Nierenberg AA
    Compr Psychiatry; 2003; 44(1):44-50. PubMed ID: 12524635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder.
    Amital D; Fostick L; Silberman A; Calati R; Spindelegger C; Serretti A; Juven-Wetzler A; Souery D; Mendlewicz J; Montgomery S; Kasper S; Zohar J
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):895-901. PubMed ID: 23121858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder.
    Papakostas GI
    Essent Psychopharmacol; 2005; 6(4):209-20. PubMed ID: 16041917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder.
    Ivanova JI; Birnbaum HG; Kidolezi Y; Subramanian G; Khan SA; Stensland MD
    Curr Med Res Opin; 2010 Oct; 26(10):2475-84. PubMed ID: 20825269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.
    Nierenberg AA; Alpert JE; Gardner-Schuster EE; Seay S; Mischoulon D
    Biol Psychiatry; 2008 Sep; 64(6):455-60. PubMed ID: 18571625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of life events in depression in primary medical care versus psychiatric settings.
    Coyne JC; Thompson R; Pepper CM
    J Affect Disord; 2004 Nov; 82(3):353-61. PubMed ID: 15555686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of life events in adolescents with major depression, borderline personality disorder and matched controls: a pilot study.
    Horesh N; Ratner S; Laor N; Toren P
    Psychopathology; 2008; 41(5):300-6. PubMed ID: 18594165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
    Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
    JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment resistant depression--advances in somatic therapies.
    Kennedy SH; Giacobbe P
    Ann Clin Psychiatry; 2007; 19(4):279-87. PubMed ID: 18058285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-resistant depression.
    Souery D; Papakostas GI; Trivedi MH
    J Clin Psychiatry; 2006; 67 Suppl 6():16-22. PubMed ID: 16848672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities.
    Gaynes BN
    J Clin Psychiatry; 2009; 70 Suppl 6():10-5. PubMed ID: 19922739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life stress and the long-term treatment course of recurrent depression: III. Nonsevere life events predict recurrence for medicated patients over 3 years.
    Monroe SM; Torres LD; Guillaumot J; Harkness KL; Roberts JE; Frank E; Kupfer D
    J Consult Clin Psychol; 2006 Feb; 74(1):112-20. PubMed ID: 16551148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.